根据最新提交的招股说明书文件,Aptevo Therapeutics Inc. 的现有股东计划出售最多7,075,471股公司普通股。此次股份出售将由售股股东进行,公司本身不会从本次交易中获得任何收益。
根据最新提交的招股说明书文件,Aptevo Therapeutics Inc. 的现有股东计划出售最多7,075,471股公司普通股。此次股份出售将由售股股东进行,公司本身不会从本次交易中获得任何收益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.